KARD compared with IMTX: revenue, margins and what each company keeps, and the suppliers and customers both name

KARDKardigan, Inc.

Mkt capRevenueRevenue

IMTXImmatics N.V.

Mkt capRevenueRevenue

Compare

KARDKardigan, Inc.

IMTXImmatics N.V.

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Revenue flow

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

KARDKardigan, Inc.

14.22▲+0.66%· post 14.22· delayed

Mkt cap$356.0M

IMTXImmatics N.V.

7.05▼−2.03%· post 7.05· delayed

After hoursNov 2 '26delayed

Mkt cap$965.3M

Compare

After hoursNov 2 '26delayed

KARDKardigan, Inc.

IMTXImmatics N.V.

14.22▲+0.66%post 14.22delayed

Price

7.05▼−2.03%post 7.05delayed

$356.0M

Mkt cap

$965.3M

KARD14.22▲+0.66%vsIMTX7.05▼−2.03%After hoursNov 2 '26delayed

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Price

Supply-chain overlap

Revenue flow

KARD: latest quarter not drawable. IMTX: latest quarter not drawable.Method ›

Supply-chain overlap

direct ties · both sidesSources ›

direct ties · both sides

Only KARD 1

—Ionis Pharmaceuticalsunlistedsupplier

Shared 0

No shared counterparties.

Only IMTX 2

BMYBristol-Myers Squibbcustomer

MRNAModernaTXcustomer

Role chip = supplier or customer—= no ticker (unlisted)Source: SEC EDGAR

Price

rebased to 0%

KARD, solidIMTX, dashed